Y-mAbs Therapeutics Inc
NASDAQ:YMAB
Y-mAbs Therapeutics Inc
NASDAQ:YMAB
Price:
8.61
USD
Market Closed
Market Cap:
$391.2m
Add Note
Add Target
Capture your thoughts and set a target
Decide at what price you'd be comfortable buying and we'll help you stay ready.
Based on
Margin of Safety
0%
10%
20%
30%
40%
50%
Your Price Target
Linked to
current price
· In Buy Zone
Loading
Note attached
Choose the stock you wish to monitor with a price target
Recently Viewed
|
Y-mAbs Therapeutics Inc
NASDAQ:YMAB
|
US |
|
L
|
L & K Engineering Co Ltd
TWSE:6139
|
TW |
|
Eni SpA
MIL:ENI
|
IT |
|
Wendel SE
PAR:MF
|
FR |
|
B
|
Brilliant AG
XBER:BAG
|
DE |
|
Towne Bank
NASDAQ:TOWN
|
US |
|
DIRTT Environmental Solutions Ltd
TSX:DRT
|
CA |
|
G
|
General Mills Inc
SWB:GRM
|
US |
|
P
|
Palfinger AG
DUS:PFI
|
AT |
|
CNB Financial Corp
NASDAQ:CCNE
|
US |
|
N
|
Northrop Grumman Corp
F:NTH
|
US |
|
Canadian National Railway Co
TSX:CNR
|
CA |
|
A
|
Ameresco Inc
F:4AM
|
US |
|
C
|
Cognizant Technology Solutions Corp
DUS:COZ
|
US |
|
S
|
Southern Copper Corp
DUS:PCU
|
US |
|
T
|
Tsakos Energy Navigation Ltd
F:TK41
|
GR |
|
Teva Pharmaceutical Industries Ltd
TASE:TEVA
|
IL |
|
P
|
Pecoy Copper Corp
XTSX:PCU
|
CA |
|
Laurent Perrier SA
PAR:LPE
|
FR |
|
First Citizens BancShares Inc (Delaware)
NASDAQ:FCNCA
|
US |
|
Brightstar Resources Ltd
ASX:BTR
|
AU |
Why do you have more estimates than other sites?
Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What you see on other sites is mostly sourced from sell-side analysts.
What is YMAB's stock price target?
Not Available
YMAB does not have any price targets made by Wall Street professionals.
What is the Revenue forecast for Y-mAbs Therapeutics Inc?
Projected CAGR
8%
8%
The compound annual growth rate for Revenue over the next 3 years is 8%.
